[go: up one dir, main page]

UY24989A1 - Carprofeno, un inhibidor de cox-2, útil en el tratamiento del dolor e inflamación en perros - Google Patents

Carprofeno, un inhibidor de cox-2, útil en el tratamiento del dolor e inflamación en perros

Info

Publication number
UY24989A1
UY24989A1 UY24989A UY24989A UY24989A1 UY 24989 A1 UY24989 A1 UY 24989A1 UY 24989 A UY24989 A UY 24989A UY 24989 A UY24989 A UY 24989A UY 24989 A1 UY24989 A1 UY 24989A1
Authority
UY
Uruguay
Prior art keywords
cox
inhibitor
activity
dogs
carprophen
Prior art date
Application number
UY24989A
Other languages
English (en)
Spanish (es)
Inventor
Ricketts Anthony Paul
Lundy Kristin Marie
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of UY24989A1 publication Critical patent/UY24989A1/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)
UY24989A 1997-05-05 1998-05-04 Carprofeno, un inhibidor de cox-2, útil en el tratamiento del dolor e inflamación en perros UY24989A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
UY24989A1 true UY24989A1 (es) 2001-10-25

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
UY24989A UY24989A1 (es) 1997-05-05 1998-05-04 Carprofeno, un inhibidor de cox-2, útil en el tratamiento del dolor e inflamación en perros

Country Status (32)

Country Link
EP (1) EP0988034A1 (is)
JP (1) JP2000513020A (is)
KR (2) KR20010012300A (is)
CN (1) CN1255059A (is)
AP (1) AP9801234A0 (is)
AR (2) AR011726A1 (is)
AU (1) AU6932198A (is)
BG (1) BG103852A (is)
BR (1) BR9808720A (is)
CA (1) CA2288759A1 (is)
DZ (1) DZ2479A1 (is)
EA (1) EA003696B1 (is)
GT (1) GT199800063A (is)
HR (1) HRP980244A2 (is)
HU (1) HUP0001286A3 (is)
ID (1) ID21311A (is)
IL (1) IL132570A0 (is)
IS (1) IS5220A (is)
MA (1) MA26491A1 (is)
NO (1) NO995389L (is)
NZ (1) NZ500183A (is)
OA (1) OA11213A (is)
PA (1) PA8450601A1 (is)
PE (1) PE72599A1 (is)
PL (1) PL337003A1 (is)
SK (1) SK148199A3 (is)
TN (1) TNSN98059A1 (is)
TW (1) TW590773B (is)
UY (1) UY24989A1 (is)
WO (1) WO1998050033A1 (is)
YU (1) YU55899A (is)
ZA (1) ZA983722B (is)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
EP1123091A1 (en) * 1998-10-23 2001-08-16 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
EP1637137A3 (en) * 1999-03-10 2006-07-05 G.D. Searle LLC Method and composition for administering a cyclooxygenase-2 inhibitor to animals
WO2001034204A1 (en) * 1999-11-11 2001-05-17 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
US20020016342A1 (en) * 2000-05-15 2002-02-07 Edward Scolnick Combination therapy using COX-2 selective inhibitor and thromboxane inhibitor and compositions therefor
US6924303B2 (en) 2000-06-13 2005-08-02 Wyeth Analgesic and anti-inflammatory compositions containing COX-2 inhibitors
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
CA2422803A1 (en) 2000-08-07 2002-02-14 Vanderbilt University Detection of cox-2 activity and anandamide metabolites
US20040209959A1 (en) * 2001-07-16 2004-10-21 Edward Hogestatt Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation
PL2266585T3 (pl) 2003-05-07 2013-10-31 Osteologix As Rozpuszczalne w wodzie sole stronktu do stosowania w leczeniu chorób chrząstki i/lub kości
EP1651210A1 (en) * 2003-07-31 2006-05-03 Pharmacia & Upjohn Company LLC Dispersible formulation of an anti-inflammatory agent
US20080269310A1 (en) * 2005-05-20 2008-10-30 Adrian Paul Foster Synergistic Combinations
CA2683415C (en) 2007-04-04 2020-12-08 Sigmoid Pharma Limited An oral pharmaceutical composition
WO2008132707A1 (en) 2007-04-26 2008-11-06 Sigmoid Pharma Limited Manufacture of multiple minicapsules
JP5640079B2 (ja) 2009-05-18 2014-12-10 シグモイド・ファーマ・リミテッドSigmoid Pharma Limited 油滴含有組成物
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
ES2907285T3 (es) * 2014-03-06 2022-04-22 Elanco Animal Health Incorporated Composiciones de grapiprant y procedimientos de uso de las mismas
EA036036B1 (ru) 2014-11-07 2020-09-16 Сигмойд Фарма Лимитед Композиции, содержащие циклоспорин
EP3242557A4 (en) * 2015-01-09 2018-09-05 Jaguar Health, Inc. Methods of treating diarrhea in companion animals
JP2023520367A (ja) * 2020-03-25 2023-05-17 エスアールアイ インターナショナル リポキシゲナーゼ阻害剤
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
EP0988034A1 (en) 2000-03-29
TW590773B (en) 2004-06-11
EA003696B1 (ru) 2003-08-28
EA199900895A1 (ru) 2000-06-26
OA11213A (en) 2003-07-14
BG103852A (en) 2000-06-30
MA26491A1 (fr) 2004-12-20
WO1998050033A1 (en) 1998-11-12
IL132570A0 (en) 2001-03-19
CA2288759A1 (en) 1998-11-12
PE72599A1 (es) 1999-08-12
AR039628A2 (es) 2005-03-02
HRP980244A2 (en) 1999-02-28
NZ500183A (en) 2002-04-26
AR011726A1 (es) 2000-08-30
SK148199A3 (en) 2001-09-11
AU6932198A (en) 1998-11-27
ID21311A (id) 1999-05-20
ZA983722B (en) 1999-11-04
TNSN98059A1 (fr) 2005-03-15
AP9801234A0 (en) 1999-11-04
BR9808720A (pt) 2000-07-11
CN1255059A (zh) 2000-05-31
IS5220A (is) 1999-10-19
PA8450601A1 (es) 2000-05-24
KR20040004406A (ko) 2004-01-13
KR20010012300A (ko) 2001-02-15
HUP0001286A3 (en) 2000-12-28
DZ2479A1 (fr) 2003-02-01
JP2000513020A (ja) 2000-10-03
NO995389D0 (no) 1999-11-04
NO995389L (no) 2000-01-04
HUP0001286A2 (hu) 2000-11-28
PL337003A1 (en) 2000-07-31
YU55899A (sh) 2003-08-29
GT199800063A (es) 1999-10-26

Similar Documents

Publication Publication Date Title
UY24989A1 (es) Carprofeno, un inhibidor de cox-2, útil en el tratamiento del dolor e inflamación en perros
BR0212142A (pt) Método e sistema para tratamento de acne
ES2055309T3 (es) Una composicion para el tratamiento de mamiferos que padecen de artritis reumatoide.
NO20055445L (no) Anvendelse av en blanding for fremstilling av et medikament for perioperativt a hemme smerte, betennelse og/eller spasme, og en losning for perioperativt a hemme smerte, betennelse og/eller spasme
ES2064327T3 (es) Uso de icam-1 o de sus derivados funcionales para el tratamiento de una inflamacion no especifica.
CA2241981A1 (en) Method of inhibiting photoaging of skin
ATE234090T1 (de) Kombination von duloxetin mit nichtsteroid- entzündungshemmern für die behandlung von schmerz
ES2162942T3 (es) Nuevos derivados de acidos carboxilicos, su obtencion y empleo.
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
EA200100572A1 (ru) Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии
BR9406746A (pt) Composto processo para sua preparaçao preparado farmacêutico uso de um composto processo para a obtençao da inibiçao de trombina em um organismo humano ou animale fragmento estrutural
CY1108617T1 (el) Τοπικη χρηση βαλπροϊκου οξεος για την αποτροπη η θεραπεια ψωριασης και ακμης
DE69526344D1 (de) Stabilgelzusammensetzung zur topischen behandlung von hautkrankheiten
DE3687429D1 (de) Gamma-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen.
RU94022017A (ru) Способ лечения акне или псевдофолликулита бороды, способ получения композиции, применение ингибитора фермента орнитиндекарбоксилазы для лечения акне или псевдофолликулита бороды
EA199900542A1 (ru) Соединения сульфоновой кислоты или сульфониламино-n-(гетероаралкил)-азагетероциклиламида
Ailawadi et al. A nonintrinsic regional basis for increased infrarenal aortic MMP-9 expression and activity
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
MX9304564A (es) Combinaciones de relajante muscular-ibuprofen.
IT1295357B1 (it) Formulazioni cosmetiche utili nel trattamento preventivo e curativo della caduta dei capelli e loro uso
IS2279B (is) Notkun á hliðstæðum gamma-amínósmjörsýru (GABA) áborð við GABA-pentín til vinnslu lyfs til meðferðar á bólgusjúkdómum
DE69228813D1 (de) Verwendung von 2-(2-nitro-4-trifluormethylbenzoyl)-1,3-cyclohexandion zur behandlung von tyrosinämie sowie pharmazeutische zusammensetzungen
FI962369A7 (fi) Farmaseuttinen formulointi myrkytyksen ehkäisemiseksi tai esihoidoksi organofosforisilla koliiniesteraasi-inhibiittoreilla
BR9808054A (pt) Método de tratamento e/ou prevenção de diabete melito não-dependente de insulina e composição
CO5021216A1 (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros

Legal Events

Date Code Title Description
RDES Application refused

Effective date: 20130108